Infections with Rothia mucilaginosa are rare. We present an unusual case of Rothia mucilaginosa in an immunocompromised host, which is usually considered a low virulence pathogen. The objective of this report is to highlight spectrum of clinical presentations in an immunocompromised individual and discuss various antimicrobial treatment options in the light of lack of definitive treatment guidelines for this organism.
Keywords: Rothia mucilaginosa; cerebritis; chemotherapy; immunocompromised; lung nodules; meningitis; septic emboli.
© The Author(s) 2021.